This inventor holds 21 USPTO granted patents and 2 published patent applications, primarily in Cancer Therapy. Top assignees: Auckland Uniservices Limited, Development Finance Corporation of New Zealand, Cancer Research Campaign Technology Limited. Active years: 1982-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Meadowband, Auckland 5, NZ (1989)
- Meadowbank, NZ (1994 - 1999)
- Auckland, NZ (1982 - 2010)
Company Filing History:
6 out of 255 
6 out of 31 
3 out of 62 Years Active: 1982-2010
Areas of Expertise:
Title: Graham John Atwell: Innovator in Cancer Therapy
Introduction
Graham John Atwell is a prominent inventor based in Auckland, New Zealand. With a remarkable portfolio of 20 patents, he has significantly contributed to advancements in medical technologies, particularly in cancer therapy and related fields. His innovative work emphasizes the development of prodrugs and selective treatments for cancer, showcasing his dedication to improving patient care through scientific discoveries.
Latest Patents
Among his notable inventions, Graham has recently developed two important patents. The first patent involves "Nitroaniline-based alkylating agents and their use as prodrugs". This invention focuses on a specialized method for preparing nitroaniline-based unsymmetrical mustards, with applications in gene-dependent enzyme prodrug therapy (GDEPT) and cell ablation therapy. These compounds act as hypoxia-selective cytotoxins and have potential as anticancer agents.
The second of his latest patents pertains to "Nitrobenzindoles and their use in cancer therapy". This innovation encompasses nitro-1,2-dihydro-3H-benzo[e]indoles and their analogues, which serve as hypoxia-selective drugs and radiosensitizers in cancer treatment. These compounds can be utilized alone or in combination with radiation and/or other anticancer medications, thus enhancing therapeutic outcomes.
Career Highlights
Graham Atwell has had a distinguished career marked by significant contributions to medical research and innovation. He has been associated with Auckland Uniservices Limited, where he has applied his expertise to drive advancements in technology and healthcare solutions. Additionally, his involvement with the Development Finance Corporation of New Zealand highlights his commitment to fostering innovation in the region.
Collaborations
Throughout his career, Graham has collaborated with esteemed professionals such as William Alexander Denny and Bruce Charles Baguley. These partnerships have facilitated the development of groundbreaking therapies and have strengthened the research community's ability to tackle challenging health issues.
Conclusion
Graham John Atwell's innovative contributions to cancer therapy exemplify his dedication to advancing medical science. His patents, focusing on targeted drug therapies, reflect a commitment to improving treatment modalities for cancer patients. As his work continues to progress, Graham's influence in the field of medical innovations is expected to have a profound impact on healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile